The tumor’s mesenchymal origin necessitates the demonstration of smooth muscle differentiation through positivity for SMA, desmin, and caldesmon, while excluding other sarcoma subtypes and metastatic disease (14). The gene discussed is SMN1; the disease is metastatic neoplasm.